References
Hinchey J, Chaves C, Appignani B, Breen J, Pao L, Wang A et al. A reversible posterior leukoencephalopathy syndrome. New Engl J Med 1996; 334: 494–500.
Cordelli DM, Masetti R, Zama D, Gueraldi D, Rondelli R, Cottone C et al. Etiology, characteristics and outcome of seizures after pediatric hematopoietic stem cell transplantation. Seizure 2014; 23: 140–145.
Weber C, Schaper J, Tibussek D, Adams O, Mackenzie CR, Dilloo D et al. Diagnostic and therapeutic implications of neurological complications following paediatric haematopoietic stem cell transplantation. Bone Marrow Transplant 2008; 41: 253–259.
Siegal D, Keller A, Xu W, Bhuta S, Kim DH, Kuruvilla J et al. Central nervous system complications after allogeneic hematopoietic stem cell transplantation: incidence, manifestations, and clinical significance. Biol Blood Marrow Transplant 2007; 13: 1369–1379.
Beitinjaneh A, McKinney AM, Cao Q, Weisdorf DJ . Toxic leukoencephalopathy following fludarabine-associated hematopoietic cell transplantation. Biol Blood Marrow Transplant 2011; 17: 300–308.
Noè A, Cappelli B, Biffi A, Chiesa R, Frugnoli I, Biral E et al. High incidence of severe cyclosporine neurotoxicity in children affected by haemoglobinopaties undergoing myeloablative haematopoietic stem cell transplantation: early diagnosis and prompt intervention ameliorates neurological outcome. Ital J Pediatr 2010; 36: 14.
Erer B, Polchi P, Lucarelli G, Angelucci E, Baronciani D, Galimberti M et al. CsA-associated neurotoxicity and ineffective prophylaxis with clonazepam in patients transplanted for thalassemia major: analysis of risk factors. Bone Marrow Transplant 1996; 18 (1): 157–162.
Stübgen J-P . Posterior reversible encephalopathy syndrome (PRES) after granulocyte-colony stimulating factor (G-CSF) therapy: a report of 2 cases. J Neurol Sci 2012; 321: 35–38.
Kastrup O, Diener HC . Granulocyte-stimulating factor filgrastim and molgramostim induced recurring encephalopathy and focal status epilepticus. J Neurol 1997; 244: 274–275.
Hammerstrom AE, Howell J, Gulbis A, Rondon G, Champlin RE, Popat U . Tacrolimus-associated posterior reversible encephalopathy syndrome in hematopoietic allogeneic stem cell transplantation. Am J Hematol 2013; 88: 301–305.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Zama, D., Masetti, R., Cordelli, D. et al. Risk factor analysis of posterior reversible encephalopathy syndrome after allogeneic hematopoietic SCT in children. Bone Marrow Transplant 49, 1538–1540 (2014). https://doi.org/10.1038/bmt.2014.182
Published:
Issue Date:
DOI: https://doi.org/10.1038/bmt.2014.182
- Springer Nature Limited
This article is cited by
-
Cyclosporine A-related neurotoxicity after haploidentical hematopoietic stem cell transplantation in children with hematopathy
Italian Journal of Pediatrics (2021)
-
Neuroimaging findings of posterior reversible encephalopathy syndrome (PRES) following haematopoietic stem cell transplantation in paediatric recipients
BMC Pediatrics (2021)
-
Stem cell transplantation for hemoglobinopathy Vila Real
Annals of Hematology (2021)
-
Posterior reversible encephalopathy syndrome (PRES) after haploidentical haematopoietic stem cell transplantation: incidence, risk factors and outcomes
Bone Marrow Transplantation (2020)